Faculty Opinions recommendation of Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.

Author(s):  
Shai Izraeli
Cancer Cell ◽  
2019 ◽  
Vol 36 (2) ◽  
pp. 123-138.e10 ◽  
Author(s):  
Maurice Labuhn ◽  
Kelly Perkins ◽  
Sören Matzk ◽  
Leila Varghese ◽  
Catherine Garnett ◽  
...  

Cancer Cell ◽  
2019 ◽  
Vol 36 (3) ◽  
pp. 340 ◽  
Author(s):  
Maurice Labuhn ◽  
Kelly Perkins ◽  
Sören Matzk ◽  
Leila Varghese ◽  
Catherine Garnett ◽  
...  

2018 ◽  
Vol 2 (13) ◽  
pp. 1532-1540 ◽  
Author(s):  
Marius Flasinski ◽  
Kira Scheibke ◽  
Martin Zimmermann ◽  
Ursula Creutzig ◽  
Katarina Reinhardt ◽  
...  

Key Points Low-dose cytarabine treatment reduced mortality in symptomatic TMD patients compared with the historical control. An MRD monitoring–based low-dose cytarabine treatment does not prevent progression from preleukemic TMD to ML-DS.


2004 ◽  
Vol 44 (1) ◽  
pp. 8-12 ◽  
Author(s):  
Julie A. Ross ◽  
Logan G. Spector ◽  
Leslie L. Robison ◽  
Andrew F. Olshan

2013 ◽  
Vol 8 (1) ◽  
pp. 47 ◽  
Author(s):  
Thai Tran ◽  
David Mitchell ◽  
David Dix ◽  
Sonia Cellot ◽  
Marie-Chantal Ethier ◽  
...  

2014 ◽  
Vol 62 (5) ◽  
pp. 854-858 ◽  
Author(s):  
Caroline Roncadin ◽  
Johann Hitzler ◽  
Andrea Downie ◽  
Isabelle Montour-Proulx ◽  
Cheryl Alyman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document